Atlas Trials

Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET

Clinical trial NCT03972488 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03972488
Sponsor
Advanced Accelerator Applications
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Gastro-enteropancreatic Neuroendocrine Tumor
Start date
2020-01-08
Primary completion
2023-07-20
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.